论文信息 - Phase II study of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study. - 字舞流文

Phase II study of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study.

M. Satouchi | K. Yoh | K. Goto | H. Murakami | T. Seto | K. Ohashi | M. Shimokawa | Y. Fujiwara | K. Nosaki | M. Morise | J. Sakakibara | S. Matsumoto | S. Yano